[Current trends in the experimental therapy of autoimmune diseases].
D000818:Animals; D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004247:DNA / Q000276:immunology; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007978:Levamisole / Q000627:therapeutic use; D051379:Mice; D008814:Mice, Inbred NZB; D008815:Mice, Inbred Strains; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D007978:Levamisole; D003520:Cyclophosphamide; D004247:DNA; D001215:Asparaginase
O nekotorykh aktual'nykh napravleniiakh éksperimental'noĭ terapii autoimmunnykh zabolevaniĭ.